logo
Plus   Neg
Share
Email

Fair Isaac Q2 Profit Rises - Quick Facts

Fair Isaac Corp. (FICO), an analytics and decision management technology provider, reported second quarter net income of $20.0 million or $0.55 per share, rising from $7.7 million or $0.19 per share last year.

Total revenues for the quarter increased 4 percent to $159.5 million from $152.8million a year ago.

Three analysts polled by Thomson Reuters expected revenues of $156.67 million for the quarter.

Looking ahead, the company reiterated its guidance for the fiscal 2012, wherein it expects net income of $86 million-$89 million or $2.45-$2.55 per share and revenues of $640 million-$645 million.

Analysts currently expect earnings of $2.59 per share and revenues of $645.42 million for the fiscal 2012 .

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT